Haleon plc Logo

Haleon plc (HLN)

LSE

Currency in GBp
342.40
+8.40 (+2.51%)

Closed

Oct 7, 2026

Day's Range

334.00
345.00

52 wk Range

317.80
416.10

Overview - HLN - Haleon plc

Key Statistics

Valuation

Enterprise Value

37.43B

P/E (Trailing)

‪18.75‬

P/E (Forward)

‪14.79‬

PEG Ratio

‪14.79‬

Price / Sales (TTM)

‪2.66‬

Price / Book

‪183.08‬

EV / EBITDA

‪13.14‬

Profitability

Gross Margin

‪55.38%‬

Profit Margin

‪14.55%‬

Operating Margin

‪23.93%‬

Return on Assets

‪5.08%‬

Return on Equity

‪10.09%‬

Ownership

Shares Outstanding

8.90B

Float

8.85B

Held by Insiders

‪0.06%‬

Held by Institutions

‪59.48%‬

Price stats

Beta

‪0.24‬

50-Day Avg

‪356.30‬

200-Day Avg

‪361.64‬

Dividends

Payout Ratio

‪39.23%‬

Frequency

Semi-Annual

Analyst Consensus

Buy

18 analysts

Average price target

‪£ 421.41‬

News Teaser - HLN - Haleon plc

News & Analysis

View all news

Market Cap - HLN - Haleon plc

Peers - HLN - Haleon plc

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.

Profile Summary - HLN - Haleon plc

About

Haleon plc is a global consumer health company focused on over-the-counter products that address everyday health needs. Headquartered in the United Kingdom, Haleon operates across key categories such as oral health, pain relief, respiratory health, digestive wellness, and vitamins, minerals and supplements. Its…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees24.56K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.